Slingshot members are tracking this event:

Phase 3 trial of AXS-02 for Complex regional pain syndrome (CRPS) expected to be completed by end of 2017 - Discontinued

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AXSM Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Trial, Axs-02, Complex Regional Pain Syndrome, Crps